Nomos Goes Public Via North American Scientific Merger Valued At $56 Mil.
This article was originally published in The Gray Sheet
Executive Summary
Radiation oncology firm North American Scientific, Inc. (NASI) will more than triple its revenue to $55-$60 mil. with the purchase of intensity modulated radiation therapy (IMRT) developer Nomos under an Oct. 27 agreement